Skip to main content Accessibility help
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 1
  • Print publication year: 2011
  • Online publication date: September 2011

Chapter 1 - Pathology of cavernous malformations

from Section 1 - Biology

References

1. Moriarity, J., Clatterbuck, R. & Rigamonti, D.The natural history of cavernous malformations. Neurosurg Clin N Am 1999;10:411–417.
2. Maraire, J. & Awad, I.Intracranial cavernous malformations: lesion behavior and management strategies. Neurosurgery 1995;37:591–605.
3. Notelet, L., Houtteville, J., Khoury, S., Lechevalier, B. & Chapon, F.Proliferating cell nuclear antigen (PCNA) in cerebral cavernomas: an immunocytochemical study of 42 cases. Surg Neurol 1997;47:364–370.
4. Porter, P., Willinsky, R., Harper, W. & Wallace, M.Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage. J Neurosurg 1997;87:190–197.
5. Robinson, J., Awad, I. & Little, J.Natural history of the cavernous angioma. J Neurosurg 1991;75:709–714.
6. Zabramski, J., et al. The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg 1994;80:422–432.
7. Aiba, T., et al. Natural history of intracranial cavernous malformations. J Neurosurg 1995;83:56–59.
8. Del Curling, O. J., Kelly, D. J., Elster, A. & Craven, T.An analysis of the natural history of cavernous angiomas. J Neurosurg 1991;75:702–708.
9. McCormick, W. & Nofzinger, J.“Cryptic” vascular malformations of the central nervous system. J Neurosurg 1966;24:865–875.
10. McCormick, W., Hardman, J. & Boulter, T.Vascular malformations (“angiomas”) of the brain, with special reference to those occurring in the posterior fossa. J Neurosurg 1968;28:241–251.
11. Nozaki, K., Inomoto, T., Takagi, Y. & Hashimoto, N.Spinal intradural extramedullary cavernous angioma. Case report. J Neurosurg 2003;99:316–319.
12. Er, U., Yigitkanli, K., Simsek, S., Adabag, A. & Bavbek, M.Spinal intradural extramedullary cavernous angioma: case report and review of the literature. Spinal Cord 2007;45:632–636.
13. Conway, J. E. & Rigamonti, D.Cavernous malformations: a review and current controversies. Neurosurg Quart 2006;16:15–23.
14. Baumann, C. R., et al. Seizure outcome after resection of supratentorial cavernous malformations: a study of 168 patients. Epilepsia 2007;48:559–563.
15. Simard, J., Garcia-Bengochea, F., Ballinger, W. J., Mickle, J. & Quisling, R.Cavernous angioma: a review of 126 collected and 12 new clinical cases. Neurosurgery 1986;18:162–172.
16. Bertalanffy, H., et al. Cerebral cavernomas in the adult. Review of the literature and analysis of 72 surgically treated patients. Neurosurg Rev 2002;25:1–53; discussion 54–55.
17. Wang, C., Liu, A., Zhang, J., Sun, B. & Zhao, Y. Surgical management of brain-stem cavernous malformations: report of 137 cases. Surg Neurol 2003;59:444–454; discussion 454.
18. Tomlinson, F. H., et al. Angiographically occult vascular malformations: a correlative study of features on magnetic resonance imaging and histological examination. Neurosurgery 1994;34:792–799; discussion 799–800.
19. Burger, P., Scheithauer, B. W. & Vogel, F. S.Surgical Pathology of the Nervous System and Its Coverings (New York: Churchill Livingstone, 2002).
20. Awad, I. & Jabbour, P.Cerebral cavernous malformations and epilepsy. Neurosurg Focus 2006;21:e7.
21. Uranishi, R., Awadallah, N. A., Ogunshola, O. O. & Awad, I. A. Further study of CD31 protein and messenger ribonucleic acid expression in human cerebral vascular malformations. Neurosurgery 2002;50:110–115; discussion 115–116.
22. Storer, K. P., Tu, J., Karunanayaka, A., Morgan, M. K. & Stoodley, M. A.Thrombotic molecule expression in cerebral vascular malformations. J Clin Neurosci 2007;14:975–980.
23. Kilic, T., et al. Expression of structural proteins and angiogenic factors in cerebrovascular anomalies. Neurosurgery 2000;46:1179–1191; discussion 1191–1172.
24. Sure, U., et al. Biological activity of adult cavernous malformations: a study of 56 patients. J Neurosurg 2005;102:342–347.
25. Sure, U., et al. Endothelial proliferation, neoangiogenesis, and potential de novo generation of cerebrovascular malformations. J Neurosurg 2001;94:972–977.
26. Tirakotai, W., et al. Biological activity of paediatric cerebral cavernomas: an immunohistochemical study of 28 patients. Childs Nerv Syst 2006;22:685–691.
27. Matsubara, S., Bourdeau, A., terBrugge, K. G., Wallace, C. & Letarte, M.Analysis of endoglin expression in normal brain tissue and in cerebral arteriovenous malformations. Stroke 2000;31:2653–2660.
28. Labauge, P., Denier, C., Bergametti, F. & Tournier-Lasserve, E.Genetics of cavernous angiomas. Lancet Neurol 2007;6:237–244.
29. Batra, S., Lin, D., Recinos, P., Zhang, J. & Rigamonti, D.Cavernous malformations: natural history, diagnosis and treatment. Nat Rev Neurol 2009;5:659–670.
30. Pozzati, E., Acciarri, N., Tognetti, F., Marliani, F. & Giangaspero, F.Growth, subsequent bleeding, and de novo appearance of cerebral cavernous angiomas. Neurosurgery 1996;38:662–669; discussion 669–670.
31. Ogilvy, C., Moayeri, N. & Golden, J.Appearance of a cavernous hemangioma in the cerebral cortex after a biopsy of a deeper lesion. Neurosurgery 1993;33:307–309; discussion 309.
32. Flocks, J., Weis, T., Kleinman, D. & Kirsten, W.Dose-response studies to polyoma virus in rats. J Natl Cancer Inst 1965;35:259–284.
33. Pagenstecher, A., Stahl, S., Sure, U. & Felbor, U. A two-hit mechanism causes cerebral cavernous malformations: complete inactivation of CCM1, CCM2 or CCM3 in affected endothelial cells. Hum Mol Genet 2009;18:911–918.
34. Baumgartner, J., et al. Pathologically proven cavernous angiomas of the brain following radiation therapy for pediatric brain tumors. Pediatr Neurosurg 2003;39:201–207.
35. Massa-Micon, B., Luparello, V., Bergui, M. & Pagni, C.De novo cavernoma case report and review of literature. Surg Neurol 2000;53:484–487.
36. Lüdemann, W., Ellerkamp, V., Stan, A. & Hussein, S.De novo development of a cavernous malformation of the brain: significance of factors with paracrine and endocrine activity: case report. Neurosurgery 2002;50:646–649; discussion 649–650.
37. Barr, R., Dillon, W. & Wilson, C.Slow-flow vascular malformations of the pons: capillary telangiectasias?AJNR Am J Neuroradiol 1996;17:71–78.
38. Rigamonti, D. & Spetzler, R.The association of venous and cavernous malformations. Report of four cases and discussion of the pathophysiological, diagnostic, and therapeutic implications. Acta Neurochir (Wien) 1988;92:100–105.
39. Rigamonti, D., Johnson, P., Spetzler, R., Hadley, M. & Drayer, B.Cavernous malformations and capillary telangiectasia: a spectrum within a single pathological entity. Neurosurgery 1991;28:60–64.
40. Ciricillo, S., Dillon, W., Fink, M. & Edwards, M.Progression of multiple cryptic vascular malformations associated with anomalous venous drainage. Case report. J Neurosurg 1994;81:477–481.
41. Dillon, W.Cryptic vascular malformations: controversies in terminology, diagnosis, pathophysiology, and treatment. AJNR Am J Neuroradiol 1997;18:1839–1846.
42. Awada, A., Russell, N., Al Rajeh, S. & Omojola, M.Non-traumatic cerebral hemorrage in Saudi Arabs: a hospital-based study of 243 cases. Journal of the Neurological Sciences 1996;144:198–203.
43. Abdulrauf, S., Kaynar, M. & Awad, I.A comparison of the clinical profile of cavernous malformations with and without associated venous malformations. Neurosurgery 1999;44:41–46; discussion 46–47.
44. Awad, I., Robinson, J. J., Mohanty, S. & Estes, M.Mixed vascular malformations of the brain: clinical and pathogenetic considerations. Neurosurgery 1993;33:179–188; discussion 188.
45. Wurm, G., Schnizer, M. & Fellner, F.Cerebral cavernous malformations associated with venous anomalies: surgical considerations. Neurosurgery 2005;57:42–58; discussion 42–58.
46. Porter, R., et al. Cavernous malformations of the brainstem: experience with 100 patients. J Neurosurg 1999;90:50–58.
47. Abe, M., Hagihara, N., Tabuchi, K., Uchino, A. & Miyasaka, Y.Histologically classified venous angiomas of the brain: a controversy. Neurol Med Chir (Tokyo) 2003;43:1–10; discussion 11.
48. Wilson, C.Cryptic vascular malformations. Clin Neurosurg 1992;38:49–84.
49. Clatterbuck, R., Eberhart, C., Crain, B. & Rigamonti, D.Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry 2001;71:188–192.
50. Wong, J., Awad, I. & Kim, J.Ultrastructural pathological features of cerebrovascular malformations: a preliminary report. Neurosurgery 2000;46:1454–1459.
51. Tu, J., Stoodley, M., Morgan, M. & Storer, K.Ultrastructural characteristics of hemorrhagic, nonhemorrhagic, and recurrent cavernous malformations. J Neurosurg 2005;103:903–909.